參考資料
+Ipsos Healthcare 2015年醫療營養品調查報告（香港家庭醫生）/ Ipsos Health 2015 nutrition product study (Hong Kong Family Physicians)

△基於已發表的關注血糖專用營養臨床研究

1.Diabetes Care, 2014 (37), S120-S142 (符合美國糖尿病協會之碳水化合物及脂肪建議)
Diabetes Care, 2010 (33), S13-S61 (符合美國糖尿病協會之蛋白質及脂肪建議)

2.Devitt AA et al., J Diabetes Res Clin Mtab. 2012;1:20

3.Devitt AA et al., Advances in Bioscience and Biotechnology, 2013, 4, 1-10

4.配合綜合管理，包括適量飲食及運動

5.含麥芽糊精 (Fibersol(Maltodextrin)), 舒可慢 (sucromalt), 果糖 (Fructose), 甘油 (Glycerine), 果低聚糖 (FOS)

6.2.4克/100毫升 (粉裝及即飲裝)

7.低升糖指數: GI = 41(粉裝); GI = 38(即飲裝)

8.American Diabetes Association, et al. Diabetes Care 2008; 31(Suppl. 1): S61-78

*控制及穩定糖份攝取. Diabetes Care 2018 Jan; 41 (Supplement 1): S1-S2; 世界衛生組織建議，成年人和兒童應將其每天的游離糖攝入量降至其總能量攝入的10%以下。http://www.who.int/mediacentre/news/releases/2015/sugar-guideline/zh/

此產品沒有根據《藥劑業及毒藥條例》或《中醫藥條例》註冊。為此產品作出的任何聲稱亦沒有為進行該等註冊而接受評核。此產品並不供作診斷、治療及預防任何疾病之用。

This product is not registered under the Pharmacy and Poisons Ordinance or the Chinese Medicine Ordinance. Any claim made for it has not been subject to evaluation for such registration. This product is not intended to diagnose, treat or prevent any disease.